No Prescription |
 |
 | ||
|
ACITRIN Soriatane |
|
| ||
No Prescription » Prescription Drugs 1 » ACITRIN Soriatane Actitretin is used to treat severe psoriasis (abnormal growth of skin cells that causes red thickened or scaly skin). Acitretin is in a class of medications called retinoids. The way acitretin works is not known.Actitretin comes as a capsule to take by mouth. It is usually taken once a day with the main meal. Take acitretin at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take acitretin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Your doctor may start you on a low dose of acitretin and gradually increase your dose.Acitretin controls psoriasis but does not cure it. It may take 2-3 months or longer before you feel the full benefit of acitretin. Your psoriasis may get worse during the first few months of treatment. This does not mean that acitretin will not work for you but tell your doctor if this happens. Continue to take acitretin even if you feel well. Do not stop taking acitretin without talking to your doctor.After you stop taking acitretin your symptoms may come back. Tell your doctor if this happens. Do not use leftover acitretin to treat a new flare-up of psoriasis. A different medication or dose may be needed. Buy ACITRIN Soriatane and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About ACITRIN Soriatane: Product Type: Prescription Drugs 1 ACITRIN ( Soriatane Generic Acitretin ) ACITRIN (Soriatane Generic Acitretin) Soriatane Generic Acitretin 10mg 30 (3 x 10 Capsules) 10mg 20 (2 x 10 Capsules) 10mg 10 Capsules Soriatane Generic Acitretin ACITRIN
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
